Professor Matthias Mann from the Max Planck Institute discusses his work in the field of proteomics, and explains why applying proteomics-based technologies such as timsTOF to the clinic could accelerate the diagnosis and prediction of human disease.
Dual-emission Ratiometric Fluorescence Probes
TEM Imaging Modes
Using FMR and TFR-FLIM to Image Matrix Viscosity and Membrane Fluidity
How is Additive Manufacturing Used in the Pharmaceutical Industry?
How is Chemoinformatics Used in Drug Discovery?
What is Glycobiology?
Researchers detect photoinitiators in human breast milk
Label-free multimodal imaging platform enables non-invasive study of cell cultures
Circular DNA found in cancer cells supports their survival and resistance
Applying a Proteomics-based Approach to the Clinic
New database helps identify therapeutic targets to fight infectious diseases
Scientists grow complex organoids in the lab
Using NeuroTrack Assay to Study Neurite Dynamics
Whole Cell Patch Clamp Recordings
Transplanting iPSC Derived Neural Stem Cells into the Cerebral Cortex of Neonatal Rats
Evaluating Convulsive Activity in hiPSC-Derived Neurons and Astrocytes using a Micro-Electrode Array
Neural Stem Cells for Frontotemperal Dementia and Alzheimer's Disease
Studying Astrocytes in Rett Syndrome
Professor Matthias Mann
Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.
News-Medical Life Sciences spoke to Nicholas Dupuis from Biognosys at Neuroscience 2019 about proteomics & DIA mass spectroscopy in neurodegenerative disease research.
News-Medical Life Sciences spoke to Zaber Technologies at Neuroscience 2019 to find out how they are lowering the barriers of automated microscopy.